Proteins, recommended for GLP-1 users to guard against muscle loss, have lower profit margins
A research review suggests that GLP-1 receptor agonists may help lower the risk of prostate cancer
General inflammatory markers: High-sensitivity CRP (hs-CRP), the most responsive general marker Erythrocyte sedimentation rate (ESR) Fibrinogen Condition-specific markers: Rheumatoid arthritis: RF, anti-CCP, DAS28 score Hashimoto thyroiditis: TPO antibodies, thyroglobulin antibodies, TSH Psoriasis: PASI score, BSA involvement IBD: Fecal calprotectin, SES-CD or Mayo score Lupus: ANA, anti-dsDNA, complement C3/C4 Cytokine panels (when available): TNF-alpha IL-6 IL-1 beta IL-17 (particularly relevant for psoriasis and spondyloarthritis) The recommendation from most practitioners is baseline testing before starting, a 4 to 6 week interim check, and a full reassessment at 12 weeks
A research guide to structure, biosynthesis, the GSH/GSSG redox indicator, and laboratory handling.
It contains both soluble and insoluble fiber, making it versatile for different digestive issues
Companies in these industries must understand how the GLP-1 drug market and other emerging weight loss drugs are transforming consumer behavior to capitalize on these shifts
